These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 7763692)
1. Mouse genetics in the 21st century: using gene targeting to create a cornucopia of mouse mutants possessing precise genetic modifications. Wilder PJ; Rizzino A Cytotechnology; 1993; 11(2):79-99. PubMed ID: 7763692 [TBL] [Abstract][Full Text] [Related]
3. Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Müller U Mech Dev; 1999 Apr; 82(1-2):3-21. PubMed ID: 10354467 [TBL] [Abstract][Full Text] [Related]
4. Engineering the mouse genome by site-specific recombination. Metzger D; Feil R Curr Opin Biotechnol; 1999 Oct; 10(5):470-6. PubMed ID: 10508631 [TBL] [Abstract][Full Text] [Related]
5. Lessons from the p53 mutant mouse. Jacks T J Cancer Res Clin Oncol; 1996; 122(6):319-27. PubMed ID: 8642041 [TBL] [Abstract][Full Text] [Related]
6. Embryonic stem cells as targets for gene transfer: a new approach to molecular manipulation of the murine hematopoietic system. Williams DA Bone Marrow Transplant; 1990 Mar; 5(3):141-4. PubMed ID: 2184906 [TBL] [Abstract][Full Text] [Related]
7. Generation of mouse mutants as a tool for functional genomics. Nolan PM Pharmacogenomics; 2000 Aug; 1(3):243-55. PubMed ID: 11256576 [TBL] [Abstract][Full Text] [Related]
8. Using embryonic stem cells to introduce mutations into the mouse germ line. Robertson EJ Biol Reprod; 1991 Feb; 44(2):238-45. PubMed ID: 2009325 [TBL] [Abstract][Full Text] [Related]
9. Gene Targeted Mice with Conditional Knock-In (-Out) of NMDAR Mutations. Sprengel R; Eltokhi A; Single FN Methods Mol Biol; 2017; 1677():201-230. PubMed ID: 28986875 [TBL] [Abstract][Full Text] [Related]
11. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases. Linder CC Lab Anim (NY); 2001 May; 30(5):34-9. PubMed ID: 11385732 [TBL] [Abstract][Full Text] [Related]
12. Genetic engineering in the mouse: tuning TNF/TNFR expression. Douni E; Alexiou M; Kollias G Methods Mol Med; 2004; 98():137-70. PubMed ID: 15064438 [TBL] [Abstract][Full Text] [Related]
13. Genetically altered mouse models: the good, the bad, and the ugly. Thyagarajan T; Totey S; Danton MJ; Kulkarni AB Crit Rev Oral Biol Med; 2003; 14(3):154-74. PubMed ID: 12799320 [TBL] [Abstract][Full Text] [Related]
14. Modifying the mouse: design and desire. Bradley A; Hasty P; Davis A; Ramirez-Solis R Biotechnology (N Y); 1992 May; 10(5):534-9. PubMed ID: 1368233 [TBL] [Abstract][Full Text] [Related]
15. [Studies of physiological functions of cytokines by generating mutant mice through the transgenic and the gene-targeting technology]. Kitamura D Nihon Rinsho; 1992 Aug; 50(8):1763-8. PubMed ID: 1433965 [TBL] [Abstract][Full Text] [Related]
16. Exploring development and disease through germ-line genetic engineering in the mouse. Reeves RH Anat Rec; 1998 Feb; 253(1):19-23. PubMed ID: 9556021 [TBL] [Abstract][Full Text] [Related]
17. Mutagenic insertion and chromosome engineering resource (MICER). Adams DJ; Biggs PJ; Cox T; Davies R; van der Weyden L; Jonkers J; Smith J; Plumb B; Taylor R; Nishijima I; Yu Y; Rogers J; Bradley A Nat Genet; 2004 Aug; 36(8):867-71. PubMed ID: 15235602 [TBL] [Abstract][Full Text] [Related]
19. Beyond 'knock-out' mice: new perspectives for the programmed modification of the mammalian genome. Cohen-Tannoudji M; Babinet C Mol Hum Reprod; 1998 Oct; 4(10):929-38. PubMed ID: 9809673 [TBL] [Abstract][Full Text] [Related]